NCT04528199View on ClinicalTrials.gov

[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

April 21, 2023

Study Completion Date

April 21, 2023

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

[18F]FLOR (FC303) Injection

Single dose of 10 ±1 millicurie (mCi) of \[18F\]FLOR (FC303) injection followed by the PET/CT scan.

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

Sponsors

Collaborators (1)

FutureChem
All Listed Sponsors
collaborator

FutureChem

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER